Heart failure & cardiomyopathiesCohort study

Attitudes towards using single-pill combination (polypill) therapy in heart failure: patients' and physicians' perspectives

ESC Heart FailPublished

  • Two prospective, electronic surveys
  • physician-oriented survey (22 questions) distributed internationally
  • patient-oriented survey (11 questions)

Authors' conclusion

Both physicians and patients showed strong openness and willingness towards an HF-specific SPC, supporting further development and evaluation of HF-specific polypill strategies.

Study context

Population
Physicians and patients, regarding a polypill in heart failure (HF) with ejection fraction ≤50%250 physicians and 126 patients participated · physicians 250 · patients 126
Participants
250 vs 126
Exposure
physicians vs patients
  • physiciansn = 250
  • patientsn = 126

Main finding

As reported in the abstract

Physician attitudes towards GDMT simplification and an HF-specific SPC
Physicians reporting a clear need for strategies to simplify guideline-directed medical therapy (GDMT) optimisation in HFrEF
77%
Barrier: cost
66%
Barrier: polypharmacy
54%
Physicians recognizing a real clinical need for an HF-specific single-pill combinations (SPC)
95%
Perceived clinically useful
88%
Perceived logistically feasible
76%
Perceived acceptable to patients
94%
Would use it regularly
48%
Would use it in selected patients
49%
Preferred composition: beta-blocker, mineralocorticoid receptor antagonist (MRA), and SGLT2 inhibitor
61.2%

Observational data: associations, not effects.

Further findings

Patient medication burden, adherence and attitudes towards an HF-specific SPC

Patients taking ≥6 drugs daily
70%
Admitted to occasional non-adherence
75%
Would support a solution that reduces the pill burden
82%
Would take an HF-specific SCP if offered, particularly if there is no extra cost
83%

Original publication

Attitudes towards using single-pill combination (polypill) therapy in heart failure: patients' and physicians' perspectives. ESC Heart Fail. Published 11 February 2026. doi:10.1093/eschf/xvag044

Summarised from the published abstract; every number is checked against it